Article
Genomics and transcriptomic alterations of the glutamate receptors in acute myeloid leukemia.
Clinical and translational science - 1 Oct 2023
Alqahtani Amani, Wang Mengxi, Lou Mimi, Alachkar Houda
Abstract excerpt
Glutamine and glutamate have been widely explored as potential therapeutic targets in acute myeloid leukemia (AML). In addition to its bioenergetic role in leukemia cell proliferation, L-glutamate is a neurotransmitter that acts on glutamate receptors. However, the role of glutamate receptors in AML is largely understudied. Here, we comprehensively analyze the genomic and transcriptomic alterations of glutamate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
